baber/WOPTO huggingface dataset:
Patent DE-69405638-D1 (DE)
Inventor: LECOMTE SOPHIE
IPC: A61Q1/08
Filed: 1994-05-04
Granted: 1997-10-23
Abstract: Method of manufacturing a solid cosmetic composition with the help of plaster, in which:   - a pulverulent mixture (P) consisting of the following is prepared:       1) calcium sulphate hemihydrate (CaSO4 . 1/2 H2O) in powder form, 2) a hydrophobic fraction (FO) comprising at least one fatty substance and/or at least one pulverulent material which has been treated by chemical grafting or coating so as to impart hydrophobic characteristics thereto, 3) a hydrophilic fraction (FI) in powder form, the FI/FO weight proportion being between 0.08 and 7.5;     - an aqueous phase (AP) is prepared in liquid form; - the pulverulent mixture (P) and the aqueous phase (AP) are blended in a P/AP weight proportion of between 0.2 and 2, so as to obtain a flowable mixture;   - the flowable mixture is poured into a mould; - it is left to harden (set) by hydration of the calcium sulphate hemihydrate to calcium sulphate dihydrate (CaSO4.2H2O) and is removed from the mould.
Patent DE-69414850-D1 (DE)
Inventor: GOODMAN JACK
IPC: G01N1/00
Filed: 1994-06-24
Granted: 1999-01-07
Abstract: A liquid transfer device including a holder for a pipette array. A flexible preformed membrane (17) having cups (19) is over the proximal openings of the pipettes (23) and sandwiched therebetween with a housing (11) with the cups extending into the proximal openings of the pipettes. A vacuum drawn in the housing everts the membrane from the proximal openings thereby creating reduced pressure in the pipettes which when their distal ends are immersed in a liquid will draw up some of the liquid into the pipettes in substantially equal amounts. In one embodiment a movable abutment (13) is provided to control the upward travel of the everting membrane and thereby the amount of liquid drawn into the pipettes. A method for fabricating the preformed membrane is also shown. <IMAGE>
Patent DE-69425336-D1 (DE)
Inventor: FAGGION ANDRE
IPC: G06F17/30
Filed: 1994-12-29
Granted: 2000-08-24
Abstract: An apparatus and a system for use in the field of so-called "multimedia" learning activities for linking tutors and authors of methods with their students while enabling continuous and customised follow-up and adaptation of the work plan. Data bank access and customised user management systems are also provided.
Patent DE-69431372-D1 (DE)
Inventor: IMLER JEAN-LUC
IPC: A61K48/00
Filed: 1994-05-27
Granted: 2002-10-17
Abstract: New replication-defective adenoviruses are selected from: (a) those that are derived from a natural adenovirus and lack at least the coding sequences of the E1B region and/or at least part of the E4 region; (b) those that are derived from a natural adenovirus other than a human type 5 adenovirus (Ad5) and lack part of the encapsidation region; (c) those that are derived from Ad5 and lack the part of the encapsidation region corresp. to nucleotides 270-346 in the Genbank M73260 sequence; and (d) those that are derived from Ad5 and lack the part of the encapsidation region corresp. to nucleotides 184-273 in the Genbank M73260 sequence. Also claimed is a eukaryotic cell contg. an adenovirus as above. Also claimed are: (1) a complementation line comprising a cell line contg. a complementation element which comprises at least part of the E1 region of a natural adenovirus and lacks the 5' ITR sequence, the element being integrated into the genome or inserted into a vector: and (2) a process for producing a defective adenovirus as above, comprising introducing the virus into a complementation line as above, culturing the cell line, and recovering the virus from the culture supernatant.
Patent DE-69435223-D1 (DE)
Inventor: GREGORY RICHARD J
IPC: A61K35/76
Filed: 1994-10-25
Granted: 2009-09-03
Abstract: This invention provides a recombinant adenovirus expression vector comprising a total deletion of a protein IX DNA and a gene encoding an anti-tumor protein. A pharmaceutical composition comprising said vector and its use for the treatment of cancer, especially hepatocellular carcinoma, are also part of the invention.
Patent DE-69511065-D1 (DE)
Inventor: LAU CHUNG
IPC: A61G17/007
Filed: 1995-11-07
Granted: 1999-09-02
Abstract: PCT No. PCT/IB95/00972 Sec. 371 Date Nov. 19, 1996 Sec. 102(e) Date Nov. 19, 1996 PCT Filed Nov. 7, 1995 PCT Pub. No. WO96/15754 PCT Pub. Date May 30, 1996A coffin comprising an open receptacle assembly for receiving a corpse and a cover assembly for closing the receptacle assembly, in which coffin at least one of the receptacle assembly and the cover assembly is constructed from corrugated cardboard panels fixed to a skeletal frame structure. The corrugated cardboard panels are comprised of two or more layers of corrugated cardboard having a layer comprised of foil lining separating each layer of corrugated cardboard.
Patent DE-69516228-D1 (DE)
Inventor: VAN DER SCHRICK BERNARD
IPC: C08F4/6592
Filed: 1995-09-15
Granted: 2000-05-18
Abstract: Olefins are polymerised in contact with a catalyst system contg. (a) a solid catalytic complex based on Mg, a transition metal and a halogen, obtd. by (i) reacting (I) an oxygenated organo-Mg cpd. or a halogenated Mg cpd. with (II) an oxygenated organic cpd. or a halogenated cpd. of a transition metal of Gps. IVB or VB, to give a liq. complex, (ii) precipitating. the complex by means of a cpd. of formula AlRnX3-n, to give a solid catalytic complex, (iii) sepg. the solid complex, and (iv) treating the solid complex with a cpd. of formula AlRnX3-n, and (b) an organic cpd. of a metal of Gps. IA, IIA, IIB, IIIA or IVB. R = hydrocarbo gp.; X = halogen; n = less than 3.
Patent DE-69518182-D1 (DE)
Inventor: AKIRA MIIKE
IPC: G01N33/58
Filed: 1995-04-10
Granted: 2000-09-07
Abstract: The present invention provides a new analytical method that an antigen, an antibody or a nucleic acid can be assayed at a high sensitivity in the immunoassay. The present invention provides a method for assaying a substance which comprises the steps of (a) reacting an antigen, an antibody or a nucleic acid which is the substance to be measured with an antibody, an antigen or a nucleic acid to which a polyacridinium compound is bound and which can be bound to the substance to be measured, (b) carrying out a luminescence treatment, and (c) measuring the luminescent intensity of the reaction solution.
Patent DE-69522007-D1 (DE)
Inventor: FREY W
IPC: A61B19/00
Filed: 1995-04-18
Granted: 2001-09-06
Abstract: A method and system are provided for eroding or ablating a shaped volume of an eye's corneal tissue (10) in accordance with the treatment of a specified eye condition. To determine the laser beam shot pattern, a plurality of laser beam shots of uniform intensity are first selected to form a uniform shot pattern of uniform shot density. The laser beam shots applied in accordance with the uniform shot pattern of uniform shot density would be capable of eroding a volume of the corneal tissue (10) of uniform height. The volume of uniform height is approximately equivalent to that of the shaped volume. The laser beam shots are applied to the corneal tissue in a spatially distributed pattern spread over an area approximately equivalent to the surface area of the shaped volume to be eroded. The spatially distributed pattern extends the uniform shot pattern in fixed angles from a reference position on the shaped volume representative of the shaped volume's axis of symmetry. Shot density for the laser beam shots changes in correspondence with distance from the reference position.
Patent DE-69535858-D1 (DE)
Inventor: BENSON DAVID K
IPC: A47J41/02
Filed: 1995-01-27
Granted: 2008-11-20
Abstract: A catalytic converter (10,140) is surrounded by variable conductance insulation (30,164) for maintaining the operating temperature of the catalytic converter (10,140) at an optimum level, for inhibiting heat loss when raising catalytic converter temperature to light-off temperature, for storing excess heat to maintain or accelerate reaching light-off temperature, and for conducting excess heat away from the catalytic converter (10,140) after reaching light-off temperature. The variable conductance insulation (30,164) includes vacuum gas control and metal-to-metal thermal shunt mechanisms (134). Radial and axial (138) shielding inhibits radiation and convection heat loss. Thermal storage media includes phase change material (150), and heat exchanger chambers (164) and fluids (166) carry heat to and from the catalytic converter (10,140).
Patent DE-69600507-D1 (DE)
Inventor: ROSSINI FELICE
IPC: B41F27/00
Filed: 1996-03-01
Granted: 1998-09-17
Abstract: A printing cylinder mandrel (1) arranged to support a sleeve mounted on it and carrying the print characters, the mandrel (1) being surface-deformable and able to assume at least two configurations, in one of which the sleeve can be mounted on it and in the other of which the sleeve is torsionally locked to it, the mandrel (1) comprising a core (2) the surface of which is covered with a deformable element (8), between this latter and said core there being provided a plurality of intercommunicating perimetral chambers (10) containing an incompressible fluid; the mandrel (1) internally houses presser means (20) arranged to pressurize said fluid in order to achieve the surface deformation of the mandrel (1) and the torsional coupling and locking of the sleeve, said presser means (20) being guidedly movable within the mandrel (1) and being activated by feeding into this latter a pressurized fluid. <IMAGE>
Patent DE-69604087-D1 (DE)
Inventor: CALLEGARO LANFRANCO
IPC: C08B37/08
Filed: 1996-12-19
Granted: 1999-10-07
Abstract: PCT No. PCT/EP96/05701 Sec. 371 Date Jul. 12, 1998 Sec. 102(e) Date Jul. 12, 1998 PCT Filed Dec. 19, 1996 PCT Pub. No. WO97/22629 PCT Pub. Date Jun. 26, 1997A process for preparing a hyaluronic acid fraction having an average molecular weight comprised between 5000 and 300,000 and a polydispersion index lower than 1.7, comprising treating the starting high molecular weight hyaluronic acid, contemporaneously with sodium hypochlorite and ultrasounds.
Patent DE-69606563-D1 (DE)
Inventor: CITTADINI PAOLO
IPC: E06B7/23
Filed: 1996-04-30
Granted: 2000-03-09
Abstract: A weather strip in particular for window and door frames having a base portion (2) arranged to be engaged in a respective anchoring area (3) of a first bearing frame (4). A head portion (5) of the weather strip is arranged to act against an abutment area (6) associated with the a second bearing frame (7). A band of magnetic material (8) is associated with the head portion, and there is an intermediate connecting portion (9) formed, in transverse section, by a single fillet element connecting the head portion with the base portion.
Patent DE-69624010-D1 (DE)
Inventor: YAMADA KOICHIRO
IPC: C07D401/14
Filed: 1996-05-14
Granted: 2002-10-31
Abstract: Novel sulfonamide derivatives of the formula [I]: wherein Ring A and Ring B are substituted or unsubstituted monocyclic, bicyclic or tricyclic hydrocarbon, or substituted or unsubstituted heterocyclic group, Q is single bond, -O-, -S-, -SO-, -SO<sub>2</sub>- or -CH<sub>2</sub>-, Y is -O-, -S- or -NH-, Alk is lower alkylene or alkenylene, Z is -O - or -NH -, R is substituted or unsubstituted aromatic heterocyclic or aryl, R<sup>1</sup> is H, trifluoromethyl, substituted or unsubstituted amino, substituted or unsubstituted lower alkyl, alkenyl, alkynyl, substituted or unsubstituted lower alkylthio, or alkoxy, or substituted or unsubstituted heterocyclic or aryl, or pharmaceutically acceptable salts thereof, which are useful in the prophylaxis or treatment of disorders associated with endothelin activities such as hypertension, pulmonary hypertension, renal hypertension, Raynaud disease, bronchial asthma, gastric ulcer, chronic heart failure, etc.
Patent DE-69624505-D1 (DE)
Inventor: BEALL H
IPC: G02B6/00
Filed: 1996-08-07
Granted: 2002-11-28
Abstract: An athermal optical device and a method for producing the device, such as an athermal optical fiber reflective grating, are described. The athermal optical fiber reflective grating device comprises a negative expansion substrate, an optical fiber mounted on the substrate surface, and a grating defined in the optical fiber. The method for producing the athermal optical fiber reflective grating device comprises providing a negative expansion substrate, mounting an optical fiber with at least one reflective grating defined therein onto the substrate upper surface, and affixing the optical fiber to the substrate at at least two spaced apart locations.
Patent DE-69629134-D1 (DE)
Inventor: RHOADS GEOFFREY B
IPC: G06K19/14
Filed: 1996-05-07
Granted: 2003-08-21
Abstract: A method of recognising content signals in a network of computing devices, the method comprising at a first network device in the network, obtaining a content signal distributed to the first network device transforming at least a portion of the content signal into a domain for recognition analysis processing the transformed signal to compute a pattern from the content signal determining an action authorised for the content signal by matching the pattern with a set of stored patterns with corresponding authorised actions and executing the authorised action at the first network.
Patent DE-69637572-D1 (DE)
Inventor: BRONSTEIN IRENA Y
IPC: C12Q1/34
Filed: 1996-12-23
Granted: 2008-08-07
Abstract: A method of measuring the activity of at least two reporter gene products in an aliquot of a sample extract is disclosed. The activities of a first and second reporter enzyme are quantified by measuring the light signal produced by degradation of a first substrate by the first reporter enzyme and the light signal produced by the degradation of a second substrate by a second reporter enzyme. Both quantifications are sequentially performed on the same aliquot of sample extract.
Patent DE-69715707-D1 (DE)
Inventor: FAURIOT JACQUES
IPC: H01R13/447
Filed: 1997-03-17
Granted: 2002-10-31
Abstract: The socket includes a protective device (35), including the moving shutters (37), which is fixed to the mechanism (11) by a support interposed in the space in the observation window (38,39). Each window is at least sufficiently narrow locally to oppose the passage of a test finger by the normal arrangement of the insulating material of the body (12). The window is at least partially covered by a transparent disc belonging to a small transparent plate which is common to the assembly and also is fixed to and overhangs from the device. The measurement of at least one of the windows in the direction of engagement is greater than half the mean diameter of the holes at rest.
Patent DE-69723434-D1 (DE)
Inventor: VAN DER BURG HENRICUS
IPC: G01N33/569
Filed: 1997-04-28
Granted: 2003-08-14
Abstract: The present invention relates to the field of molecular biology and immunology. In particular it relates to vaccines and methods for providing vaccines which elicit immune responses when administered to a mammal, in particular a human. The preferred elicited immune response is a T cell response, elicited by peptide T cell epitopes. These vaccines find their application in many fields ranging from cancer treatments to treatments of prophylaxis of infectious diseases such as Aids. The present invention provides novel methods for selecting the peptide sequences from an intact antigen which will lead to a proper (T cell) immune response upon administration in a suitable vehicle. The epitopes and vaccines are, of course, also part of the present invention.
Patent DE-69730640-D1 (DE)
Inventor: DEL FABBRO CLAUDIO
IPC: F24C15/32
Filed: 1997-02-27
Granted: 2004-10-21
Abstract: The invention refers to a so-called fan-heater unit, adapted to be included in an apparatus such as a fan-assisted or forced-convection food cooking oven for catering or commercial applications. The unit comprises at least a tangential-type fan (32) mounted with its shaft (42) extending vertically and supported at both its ends by rolling-type journal bearings (44, 46). A main feature of the invention is that the inner ring (461) of at least a bearing (46) is mounted with a diametral clearance (480) on a corresponding end portion (422) of the shaft (42), elastic means (468) being provided which, preferably formed by at least a helical spring, are adapted to exert an axial thrust on said inner ring (461). Said axial thrust generates a friction torque capable of inducing said ring to rotate with said shaft. Advantages: Elimination of the negative effects due to instant thermal-expansion differences between the fan and the structure on which it is mounted. <IMAGE>
Patent DE-69732985-D1 (DE)
Inventor: GOLDBERG I
IPC: C12N9/64
Filed: 1997-09-15
Granted: 2005-05-12
Abstract: Disclosed are a peptide and its use in a method of screening test compounds as potential inhibitors of matrix metalloproteinases. The peptide consists of residues Trp 574 to Asp 656 in the TIMP-2 binding site of the C-terminal domain of gelatinase-A as shown by SEQ ID NO:19. The method comprises determining the inhibitory effect of a test compound in a competitive inhibition assay with said peptide in which a Ki/Kd=>1 is deemed an inhibitory effect of said test compound, and in which Ki is the inhibitor constant of said test compound and Kd is the dissociation constant of said peptide.
Patent DE-69737418-D1 (DE)
Title: Protein having an activity of suppressing aging
Inventor: NABESHIMA YOUICHI
IPC: C12N5/10
Filed: 1997-12-12
Granted: 2007-04-12
Abstract: A polypeptide having the activity of retarding aging; a DNA encoding this polypeptide; a method for breeding livestock with the use of this DNA; a recombinant DNA obtained by integrating this DNA into a vector; a transformant containing this recombinant; a process for producing the above polypeptide by using the transformant; an antibody capable of recognizing the polypeptide; a ligand for the polypeptide; a compound inhibiting the specific bond between the polypeptide and this ligand; a compound promoting the expression of the aging-retarding gene encoding the aging-retarding polypeptide; an oligonucleotide having a sequence consisting of 10 to 50 bases in the base sequence of the above DNA; and remedies for early aging, remedies for adult diseases, and aging resistors prepared with the use of the same.
Patent DE-69800136-D1 (DE)
Inventor: MORIN JEAN-XAVIER
IPC: B09B3/35
Filed: 1998-01-29
Granted: 2000-06-15
Abstract: Installation for fixing the energy value of urban waste and similar with a crushing mill (1) in which the refuse is sorted into a first flow of inert material containing little organic material and a second flow of inert material containing organic material or heavy combustible elements. This second flow is evacuated through a first exit. The installation also contains a circulating fluidized bed reactor (2) which received the crushed waste; a cyclone (11) for separating out solids which treats the gases from the reactor; a heat recovery unit (15) into which the gases pass from the cyclone and which contains a first heat exchanger assembly (18) and a dust extraction funnel into which are evacuated the solid particles via a second outlet; a second heat exchanger assembly (23) in a chamber (22) containing the gases, and a final treatment device for the gases in which the solids formed during treatment are extracted via a third outlet. The installation has an independent fusion and vitrification furnace (6) connected to each outlet by controlled connecting pipes.
Patent DE-69806413-D1 (DE)
Inventor: MAMBRETTI RICCARDO
IPC: B63B1/04
Filed: 1998-02-18
Granted: 2002-08-08
Abstract: A V-bottom for fast motor boats with longitudinal reaction walls reacting to a lateral trust from an air-water mixture which are substantially parallel and symmetrical in relation to keel is formed so that the reaction walls are the walls of flat-based grooves in a bottom joined to a flat base by a widely curving radius, or the reaction walls are the walls of ribs having a substantially trapezoidal cross-section and a flat horizontal lesser external base.</PTEXT>
Patent DE-69812111-D1 (DE)
Inventor: RENSON LUC LOUIS
IPC: E06B7/082
Filed: 1998-11-30
Granted: 2003-04-17
Abstract: A system of lamellae for a ventilation device comprises a series of horizontal lamellae (3), which are disposed above one another and at a distance from one another and enclose ventilation gaps (4) between them, as well as means for supporting the lamellae (3), comprising at least one upright (1) and a series of lamella holders (2) which are attached to the upright (1) and each support a lamella (3), which upright (1) has an undercut slot (5) in which a widened head (7) of each lammella holder (2) is accommodated. At least one of the lamella holder (2) has a head (7) with a dimension h transverse to the width direction of the head which is at most equal to the width b of the opening (6) which provides access to the said slot (5). <IMAGE>   <IMAGE>
Patent DE-69820614-D1 (DE)
Inventor: HEAD CLIFFORD
IPC: A61P11/06
Filed: 1998-05-29
Granted: 2004-01-29
Abstract: Tyrosine derivatives of formula (1) are described: in which R is (1) a group R1X1- where R1 is an optionally substituted alkyl or aromatic group, and X1 is a covalent bond or a -(CH2)n- [where n is an integer 1 or 2], -C(O)-, -CH2C(O)-, -NHC(O)-, -CH2NHC(O)-, or -SO2- group, or (2) a group (Hal1)3CSO2-, where Hal1 is a fluorine or chlorine atom; R2 and R3, which may be the same or different, is each a hydrogen or halogen atom or an alkyl, alkoxy, hydroxyl or nitro group; Alk is an alkylene chain; m is zero or an integer 1; R4 is a hydrogen atom or a methyl group; R5 is a group -(CH2)pCO2R8 where p is zero or an integer 1 and R8 is a hydrogen atom or an alkyl group; R6 is a hydrogen atom or an alkyl group; Y is a sulphur atom or a -S(O)q- group where q is an integer 1 or 2; X2 is a -C(O)-, -C(O)O-, -CONH- or -S(O)2- group; R7 is an optionally substituted alkyl group or an aryl or aralkyl group; and the salts, solvates and hydrates thereof. The compounds are able to inhibit the binding of  alpha 4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
Patent DE-69825976-D1 (DE)
Inventor: STROM TERRY
IPC: A61P37/06
Filed: 1998-10-30
Granted: 2004-10-07
Abstract: Methods are disclosed for reducing or ameliorating chronic rejection of a transplanted tissue by administration of an anti-IL-12 antibody, alone or in combination with other beneficial therapeutic agents.
Patent DE-69833845-D1 (DE)
Inventor: COUTURIER ALBAN
IPC: H04Q3/00
Filed: 1998-09-28
Granted: 2006-05-11
Abstract: Rather than needing to carry out a dialogue between the service representative and the provider, the bridge processes the logic cell elements and directs them to the correct location.
Patent DE-69841164-D1 (DE)
Inventor: SABA JULIE D
IPC: A01K67/027
Filed: 1998-09-29
Granted: 2009-10-29
Abstract: Compositions, methods and kits for diagnosing and treating cancer are provided. Therapeutic compositions may comprise agents that modulate the expression or activity of a sphingosine-1-phosphate lyase (SPL). Such compositions may be administered to a mammal afflicted with cancer. Diagnostic methods and kits may employ an agent suitable for detecting alterations in endogenous SPL. Such methods and kits may be used to detect the presence of a cancer or to evaluate the prognosis of a known disease. SPL polypeptides, polynucleotides and antibodies are also provided.
Patent DE-69906193-D1 (DE)
Inventor: TSUMURA KAZUNOBU
IPC: A23J3/34
Filed: 1999-07-28
Granted: 2003-04-30
Abstract: A polypeptide composition obtained by independently hydrolyzing 7S component ( beta -conglycinin) and 11S component (glycinin) of soybean protein contains hydrolysates of both 7S and 11S components and has good emulsifying and whipping capabilities and is useful for the production of food products including ices, meringues, spread pastes, beverages and farinaceous products.